Philia Labs
www.philialabs.com.au300 million people suffer from depression globally. 1 in 3 patients recovering from their first depression episode are likely to relapse into depression, with prolonged fight or flight nervous activity being a leading cause of relapse. Philia Labs is enabling better relapse management by quantifying the body’s fight or flight activity in real time. This will enable clinicians and patients to manage recovery and ultimately prevent depression from becoming a chronic disease. The Australian-based team consists of entrepreneurs, scientists, clinicians and engineers and has several clinical and technical partners in Australia and across the world.
Read more300 million people suffer from depression globally. 1 in 3 patients recovering from their first depression episode are likely to relapse into depression, with prolonged fight or flight nervous activity being a leading cause of relapse. Philia Labs is enabling better relapse management by quantifying the body’s fight or flight activity in real time. This will enable clinicians and patients to manage recovery and ultimately prevent depression from becoming a chronic disease. The Australian-based team consists of entrepreneurs, scientists, clinicians and engineers and has several clinical and technical partners in Australia and across the world.
Read moreCountry
City (Headquarters)
Melbourne
Industry
Employees
1-10
Founded
2018
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President Technology and Co - Founder
Email ****** @****.comPhone (***) ****-****Vice President Product Development , Co - Founder
Email ****** @****.comPhone (***) ****-****Acting Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Co - Founder | Head of Growth
Email ****** @****.comPhone (***) ****-****
Technologies
(13)